Literature DB >> 19262662

Cancer: Blood vessels kept quiet.

Andrew V Benest, Hellmut G Augustin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19262662     DOI： 10.1038/458041a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  Inhibition of hypoxia-inducible factor activity in endothelial cells disrupts embryonic cardiovascular development.

Authors:  Alexander H Licht; Felix Müller-Holtkamp; Ingo Flamme; Georg Breier
Journal:  Blood       Date:  2005-09-27       Impact factor: 22.113

2.  Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2.

Authors:  Kotaro Takeda; Vivienne C Ho; Hiromi Takeda; Li-Juan Duan; Andras Nagy; Guo-Hua Fong
Journal:  Mol Cell Biol       Date:  2006-09-11       Impact factor: 4.272

Review 3.  Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Authors:  Rakesh K Jain
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

4.  Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth.

Authors:  Patrick Nasarre; Markus Thomas; Karoline Kruse; Iris Helfrich; Vivien Wolter; Carleen Deppermann; Dirk Schadendorf; Gavin Thurston; Ulrike Fiedler; Hellmut G Augustin
Journal:  Cancer Res       Date:  2009-02-10       Impact factor: 12.701

5.  Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system.

Authors:  Kotaro Takeda; Ann Cowan; Guo-Hua Fong
Journal:  Circulation       Date:  2007-07-23       Impact factor: 29.690

Review 6.  Role and regulation of prolyl hydroxylase domain proteins.

Authors:  G-H Fong; K Takeda
Journal:  Cell Death Differ       Date:  2008-02-15       Impact factor: 15.828

7.  A role for VEGF as a negative regulator of pericyte function and vessel maturation.

Authors:  Joshua I Greenberg; David J Shields; Samuel G Barillas; Lisette M Acevedo; Eric Murphy; Jianhua Huang; Lea Scheppke; Christian Stockmann; Randall S Johnson; Niren Angle; David A Cheresh
Journal:  Nature       Date:  2008-11-09       Impact factor: 49.962

8.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia.

Authors:  Holger Gerhardt; Matthew Golding; Marcus Fruttiger; Christiana Ruhrberg; Andrea Lundkvist; Alexandra Abramsson; Michael Jeltsch; Christopher Mitchell; Kari Alitalo; David Shima; Christer Betsholtz
Journal:  J Cell Biol       Date:  2003-06-16       Impact factor: 10.539
  8 in total
  4 in total

1.  Tension in the vasculature.

Authors:  Andrew V Benest; Hellmut G Augustin
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

2.  Gene profiling of MTA1 identifies novel gene targets and functions.

Authors:  Krishna Sumanth Ghanta; Da-Qiang Li; Jeyanthy Eswaran; Rakesh Kumar
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

3.  VEGF-A165b is cytoprotective and antiangiogenic in the retina.

Authors:  Anette L Magnussen; Emma S Rennel; Jing Hua; Heather S Bevan; Nicholas Beazley Long; Christina Lehrling; Melissa Gammons; Juergen Floege; Steven J Harper; Hansjürgen T Agostini; David O Bates; Amanda J Churchill
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-17       Impact factor: 4.799

4.  Angiomodulin, a marker of cancer vasculature, is upregulated by vascular endothelial growth factor and increases vascular permeability as a ligand of integrin αvβ3.

Authors:  Eriko Komiya; Hiroki Sato; Naoko Watanabe; Marii Ise; Shouichi Higashi; Yohei Miyagi; Kaoru Miyazaki
Journal:  Cancer Med       Date:  2014-04-16       Impact factor: 4.452
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.